VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,762,030 | -56.7% | 721,668 | +13.3% | 0.00% | -50.0% |
| Q2 2023 | $15,624,972 | +10.0% | 636,974 | +4.4% | 0.00% | 0.0% |
| Q1 2023 | $14,198,353 | -23.7% | 610,157 | -17.0% | 0.00% | -33.3% |
| Q4 2022 | $18,596,446 | +48.1% | 734,747 | +12.8% | 0.01% | +50.0% |
| Q3 2022 | $12,559,000 | -35.9% | 651,373 | -15.4% | 0.00% | -42.9% |
| Q2 2022 | $19,601,000 | +2.2% | 769,564 | +3.3% | 0.01% | +16.7% |
| Q1 2022 | $19,170,000 | -37.0% | 745,328 | +2.6% | 0.01% | -33.3% |
| Q4 2021 | $30,421,000 | +0.1% | 726,536 | +4.0% | 0.01% | -10.0% |
| Q3 2021 | $30,405,000 | +9.3% | 698,644 | +18.7% | 0.01% | +11.1% |
| Q2 2021 | $27,823,000 | -2.6% | 588,456 | +5.6% | 0.01% | -10.0% |
| Q1 2021 | $28,567,000 | +96.7% | 557,172 | +2.7% | 0.01% | +66.7% |
| Q4 2020 | $14,525,000 | -21.1% | 542,371 | +1.1% | 0.01% | -25.0% |
| Q3 2020 | $18,416,000 | +346.9% | 536,435 | +433.4% | 0.01% | +300.0% |
| Q2 2020 | $4,121,000 | +691.0% | 100,563 | +561.7% | 0.00% | – |
| Q1 2020 | $521,000 | +167.2% | 15,197 | -1.7% | 0.00% | – |
| Q4 2019 | $195,000 | – | 15,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |